A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study.
Oncotarget
; 9(86): 35687-35704, 2018 Nov 02.
Article
en En
| MEDLINE
| ID: mdl-30479698
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Guideline
Idioma:
En
Año:
2018
Tipo del documento:
Article